Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 Ccorrectly Detects Aneuploidies Across All Test Samples
September 19, 2013 at 06:41 AM EDT
Illumina, Inc. (NASDAQ: ILMN ) today announced Verinata Health, an Illumina company, published additional peer-reviewed data1 showing that Verinata's non-invasive verifi® prenatal test2 correctly detects aneuploidies across all